 Daxor Corporation NYSE MKT: DXR, an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that the United States Department of Defense DOD has awarded the Company a 1.1 million contract for the development and deployment of a small, portable, highly accurate, battery-powered Blood Volume Analyzer. The value of Blood Volume Measurement for improving outcomes is further validated by this important contract from the U.S. Military for our technology, commented Daxor Corporations Chief Executive Officer Michael Feldschuh. 